We observed that in BRCA1 mutation carriers the median time from primary breast cancer diagnosis until a DNA test, was much shorter in the chemotherapy group (1.0 year) than in the non-chemotherapy group (3.4 years). The gene discussed is BRCA1; the disease is breast carcinoma.